Researchers from London, Sydney and Stanford examine the literature related to the expanded expenditure on healthcare-related drugs and devices over the last 15 years, finding an “abundance of consistent evidence demonstrating that the industry has created means to intervene in all steps of the processes that determine healthcare research, strategy, expenditure, practice and education. As a result of these interferences, the benefits of drugs and other products are often exaggerated and their potential harms are downplayed, and clinical guidelines, medical practice, and healthcare expenditure decisions are biased.” Results appear in the European Journal of Clinical Investigation.
Stamatakis, E., Weiler, R., Loannidis, J.; Undue industry influences that distort healthcare research, strategy, expenditure and practice: a review. European Journal of Clinical InvestigationMay 2013, Vol 43(5)469-75
Link to article doesn’t work.